reMYND, Bio-Incubator (Wetenschapspark)

Gaston Geenslaan 1
Leuven
Heverlee
BE-3001

Tel: 32-1675-1420
Fax: 32-1675-1421

Show jobs for this employer

2 articles about reMYND, Bio-Incubator (Wetenschapspark)

reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a

5/3/2022

reMYND NV, a clinical stage company tackling neurodegeneration, announces that its lead Alzheimer program ReS19-T has successfully completed its Phase 1 study.
Little reMYND Forges 350M+ Euros Tie-Up With Drug Giant Novo Nordisk

12/14/2017

reMYND's pre-clinical diabetes therapy ReS39 will get a significant boost after the company entered a licensing agreement with noted European diabetes company Novo Nordisk.